InMed Pharmaceuticals Inc. , a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, today announced the Company will be presenting at.
Vancouver, British Columbia (Newsfile Corp. - June 10, 2024) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a clinical stage pharmaceutical company focused on developing a pipeline
VANCOUVER, BC / ACCESSWIRE / May 28, 2024 / Stillwater Critical Minerals (TSX.V:PGE)(OTCQB:PGEZF)(FSE:J0G) (the "Company" or "SWCM") is pleased to announce that it has been invited to present at the Emerging
Appia Rare Earths & Uranium Corp. is pleased to announce that it has been invited to present at the Emerging Growth Conference on May 29th, 2024.This live, interactive online event will give.